Magnetofection is superior to other chemical transfection methods in a microglial cell line

Silke Smolders1, Sofie Kessels2, Sophie Marie-Thérèse Smolders3

  • 1UHasselt, BIOMED, Diepenbeek, Belgium; Laboratory of Neuronal Differentiation, VIB Center for the Biology of Disease, Leuven and Center for Human Genetics, KU Leuven, Leuven, Belgium.

Abstract

Insights

Glial-Mag magnetofection significantly improves DNA transfection efficiency in BV2 microglial cells. This method offers a superior alternative for transfecting microglial cell lines compared to existing chemical methods.

Area of Science:

  • Neuroscience
  • Cell Biology

Background:

  • Microglia are crucial brain immune cells involved in pathology and physiology.
  • Phagocytic cells, including microglia and the BV2 cell line, are notoriously difficult to transfect with plasmid DNA.

Purpose of the Study:

  • To evaluate the efficacy of Glial-Mag magnetofection for transfecting the BV2 microglial cell line.
  • To compare Glial-Mag magnetofection with established chemical transfection methods.

Main Methods:

  • Magnetofection using Glial-Mag, a reagent specifically designed for microglia.
  • Transfection of BV2 cells with an eGFP-expressing plasmid.
  • Measurement of transfection efficiency and IL6 secretion.

Main Results:

  • Glial-Mag magnetofection achieved a transfection efficiency of 34.95% in BV2 cells.
  • This efficiency significantly surpassed other methods like calcium-phosphate (0.34%), X-tremeGENE (3.30%), and Lipofectamine 2000 (12.51%).
  • Gene delivery resulted in transient, modest IL6 secretion, indicating minimal cell activation.

Conclusions:

  • Glial-Mag magnetofection is a highly effective method for transfecting BV2 microglial cells.
  • It offers superior transfection efficiency compared to conventional chemical methods.
  • This technique is recommended as the method of choice for chemical transfection of microglial cell lines.

Related Concept Videos